Role of C-reactive protein response to antibiotic therapy in children with a ventriculo-peritoneal shunt infection: a retrospective study

• by Kiara Rampershad, Zama Ndlondlo Princess Msibi, Basil Enicker

• November 5, 2026

DOOR framework shows similar outcomes in skin infection trials

“Using DOOR can provide clinicians and patients with a better understanding of the benefits and risks of new anti-infectives being studied to treat skin infections.” 

• by Matthew Solan

• August 24, 2026

• 7 min

Outcomes of Tuberculosis Treatment and Contributing Factors Among Patients Receiving Anti-TB Therapy in Public Health Facilities of Nekemte, Oromia Region, Western Ethiopia

• by Robsan Gudeta Getachew, Rut Oljira, Ayantu Getahun, Lemane Dereje, Milion Gebrewold Abdi, Tadesse Tolossa

• December 30, 2025

Expert panel endorse individualized beta-lactam dosing for acutely ill patients

International guidance supports concentration-guided dosing for selected acutely ill patients, with clinical cure showing the clearest benefit.

• by Doug Brunk

• August 17, 2026

• 7 min